Working to Eradicate Gynecologic Cancers

Corrado Terranova, MD

Dr
University Campus Bio-Medico of Rome
Via Alvaro del Portillo 200
Rome Italy 00128

Papers:
356 Neratinib, an irreversible pan-ErbB receptor inhibitor, is highly effective against primary cervical cancer cell lines harboring HER2/neu gene mutations